You are here

Korro Bio

4 more biotechs cut staff amid market tumult

BioPharma Dive

Fri, 05/9/25 - 09:35 am

Korro Bio merges with off-pitch Frequency, hits Wall Street with $117M

Fierce Biotech

Fri, 07/14/23 - 11:54 am

Frequency Therapeutics

Korro Bio hits the high notes with $91.5M series A to run its OPERA RNA platform

Fierce Biotech

Thu, 09/10/20 - 10:38 am

RNA editing therapies